SANUWAVE Health Files Definitive Proxy Statement

TL;DR

SANUWAVE Health filed its proxy statement, get ready for shareholder votes.

AI Summary

SANUWAVE Health, Inc. filed a Definitive Proxy Statement (DEF 14A) on July 18, 2024. This filing is related to the company's proxy materials, which are typically used for shareholder meetings to vote on corporate matters. The company, formerly known as RUB MUSIC ENTERPRISES, INC., is incorporated in Nevada and operates in the Surgical & Medical Instruments & Apparatus industry.

Why It Matters

This filing is a standard regulatory requirement for public companies, indicating upcoming shareholder decisions or corporate actions that could impact the company's direction and investor interests.

Risk Assessment

Risk Level: low — A DEF 14A filing is a routine regulatory document and does not inherently represent new risks, but rather provides information about corporate governance and shareholder actions.

Key Players & Entities

• SANUWAVE Health, Inc. (company) — Registrant
• RUB MUSIC ENTERPRISES, INC. (company) — Former company name
• 3841 (dollar_amount) — Standard Industrial Classification Code

FAQ

Key Financial Figures

• $0.001 — holders of its common stock, par value $0.001 (the " Common Stock "), to take action
• $7.7 m — egate principal amount of approximately $7.7 million, (ii) warrants to purchase an add
• $0.067 — Common Stock with an exercise price of $0.067 per share (the " First Warrants ") and
• $0.04 — Common Stock with an exercise price of $0.04 per share (the " Second Warrants ," col
• $250,000 — Price ") and (2) liquidated damages of $250,000 pro-rata based on the entire amount rai
• $4.00 — items, an initial bid price of at least $4.00 per share, and following initial listin
• $1.00 — ce of a continued bid price of at least $1.00 per share. We also believe that the Re

Filing Documents

• ny20032083x2_def14a.htm (DEF 14A) — 541KB
• logo_sanuwave02.jpg (GRAPHIC) — 40KB
• ny20032083x2_pc01.jpg (GRAPHIC) — 650KB
• ny20032083x2_pc02.jpg (GRAPHIC) — 563KB
• ny20032083x2_pvp01.jpg (GRAPHIC) — 123KB
• ny20032083x2_pvp02.jpg (GRAPHIC) — 116KB
• 0001140361-24-033485.txt ( ) — 2596KB

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This proxy statement may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations and constraints, plans for future business development activities and the proposed Reverse Stock Split and Note and Warrant (each as defined below) exchange. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond our ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance, financial condition and our ability to consummate the Reverse Stock Split and Note and Warrant exchange are risks associated with supply chain and production constraints, regulatory oversight, our ability to manage our capital resource issues, competition, our ability to obtain stockholder approval for the Reverse Stock Split and the other factors discussed in detail in our periodic filings with the SEC. We undertake no obligation to update any forward-looking statement. 4 PROPOSAL 1 APPROVAL OF THE REVERSE STOCK SPLIT PROPOSAL Our Board has adopted resolutions to authorize the Board, in its sole discretion, to (1) amend our Articles of Incorporation to effect a reverse stock split of our outstanding Common Stock and (2) direct such proposal to be submitted to the holders of our Common Stock for their approval. The amendment to our Articles of Incorporation would be accomplished by adding to the end of the third paragraph thereof referring to the number of shares with par value the following text: "Upon th

View Full Filing

View this DEF 14A filing on SEC EDGAR